OVERVIEW
FOCUS AREAS
EXPERIENCE
More than 20 years of senior leadership experience in the life sciences industry.
Innovation, operational delivery and advancing global research and development across the pharmaceutical, biotechnology, and medical device sectors.
INC Research/inVentiv
Health Syneos Health
Sharpview Ophthomology
A seasoned life sciences executive and NED board member, Rob brings an extensive background in leadership, strategic consulting, and regional business growth. His expertise in operational delivery, building consulting practices and fostering client relationships aligns with ELIQUENT’s commitment to delivering innovative, high-quality solutions to meet the evolving needs of clients. In his role at ELIQUENT, Rob oversees the company’s strategic initiatives across its regulatory, quality, and compliance practice areas, further positioning ELIQUENT to meet the growing global demand for integrated regulatory, quality, and safety solutions across diverse markets.
Prior to joining ELIQUENT, Rob served for more than six years as Senior Vice President at Syneos Health (Previously INC Research/inVentiv Health) – a leading biopharmaceutical solutions organization that provides comprehensive, integrated services across the entire product lifecycle, from clinical trials to commercialization.
Rob also brings over 20 years of senior leadership experience, including two years as a Non-Executive Director at Sharpview Ophthalmology and key positions at INC Research, Kendle, PPD, and GSK. His roles have been focused on innovation, operational delivery and advancing global research and development across the pharmaceutical, biotechnology, and medical device sectors.
-
-
SharpView Ophthalmology
SharpView Ophthalmology is a pioneering medical technology company in the field of ocular implants for macular disorders. By looking beyond boundaries and thinking differently about vision, we are creating solutions for some of the world’s most challenging eye conditions.
2022 – 2024Syneos Health
(Previously INC Research/inVentiv Health)
Syneos Health® is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success with a fully integrated suite of services across the clinical-to-commercial spectrum.
2018 – 2024INC Research
2011 – 2017
INC Research/inVentiv Health – now Syneos Health – is an end-to-end clinical and commercial solution organization for biopharmaceutical acceleration, creating better, smarter, faster ways to help clients navigate an increasingly complex marketplace.
Ready for Regulatory Clarity?
Stay informed as the regulatory landscape evolves.
Subscribe to our blog to receive the latest updates on policy changes, FDA developments, and their impact on the life sciences industry.